Robertino Mera-Giler

Company: Freenome Inc.

Job title: Head of Biostatistics, Epidemiology & Machine Learning

Seminars:

Utilizing RWE as a Component of Regulatory Submissions: Multi-Cancer Early Detection Tests 2:00 pm

• Discover RWE Study Designs for MCED clinical validation and clinical utility • Discuss the study endpoints available from RWD sources to assess clinical validity and utility • Analyze evidence generation for the Intended use of the early detection test • Examine RWE Safety endpointsRead more

day: Conference Day One